HIGH-RATE OF EXPRESSION OF MULTIDRUG RESISTANCE-ASSOCIATED P-GLYCOPROTEIN IN HUMAN ENDOMETRIAL CARCINOMA AND NORMAL ENDOMETRIAL TISSUE
- Publication type:
- Journal article
- Metadata:
-
- Autoren
- J SCHNEIDER
- T EFFERTH
- MM CENTENO
- J MATTERN
- FJ RODRIGUEZESCUDERO
- M VOLM
- Autoren-URL
- https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:A1993KJ50000018&DestLinkType=FullRecord&DestApp=WOS_CPL
- DOI
- 10.1016/S0959-8049(05)80150-9
- Externe Identifier
- Clarivate Analytics Document Solution ID: KJ500
- PubMed Identifier: 8094623
- ISSN
- 0959-8049
- Ausgabe der Veröffentlichung
- 4
- Zeitschrift
- EUROPEAN JOURNAL OF CANCER
- Paginierung
- 554 - 558
- Datum der Veröffentlichung
- 1993
- Status
- Published
- Titel
- HIGH-RATE OF EXPRESSION OF MULTIDRUG RESISTANCE-ASSOCIATED P-GLYCOPROTEIN IN HUMAN ENDOMETRIAL CARCINOMA AND NORMAL ENDOMETRIAL TISSUE
- Sub types
- Article
- Ausgabe der Zeitschrift
- 29A
Data source: Web of Science (Lite)
- Other metadata sources:
-
- Autoren
- J Schneider
- MM Centeno
- FJ Rodriguez-Escudero
- T Efferth
- J Mattern
- M Volm
- DOI
- 10.1016/s0959-8049(05)80150-9
- ISSN
- 0959-8049
- Ausgabe der Veröffentlichung
- 4
- Zeitschrift
- European Journal of Cancer
- Sprache
- en
- Paginierung
- 554 - 558
- Datum der Veröffentlichung
- 1993
- Status
- Published
- Herausgeber
- Elsevier BV
- Herausgeber URL
- http://dx.doi.org/10.1016/s0959-8049(05)80150-9
- Datum der Datenerfassung
- 2019
- Titel
- High rate of expression of multidrug resistance-associated P-glycoprotein in human endometrial carcinoma and normal endometrial tissue
- Ausgabe der Zeitschrift
- 29
Data source: Crossref
- Abstract
- The overexpression of P-glycoprotein was studied in 10 normal endometrial controls (five from the proliferative and five from the secretory phase of the menstrual cycle) and in 23 endometrial carcinomas of different histological varieties, using the C219 and JSB-1 monoclonal antibodies. Three of the tumours had been previously treated with combination chemotherapy containing doxorubicin. All endometrial carcinomas, whether treated or untreated, as well as the normal endometrial controls from both the proliferative and the secretory phase of the menstrual cycle, overexpressed P-glycoprotein. This puts endometrial carcinoma into the same category as other tumours arising in organs which normally overexpress P-glycoprotein, all of which tend to be intrinsically resistant to chemotherapy.
- Addresses
- Department of Obstetrics and Gynaecology, Hospital de Cruces, Universidad del Pais Vasco, Baracaldo, Spain.
- Autoren
- J Schneider
- T Efferth
- T Efferth
- MM Centeno
- J Mattern
- FJ Rodríguez-Escudero
- M Volm
- DOI
- 10.1016/s0959-8049(05)80150-9
- eISSN
- 1879-0852
- Externe Identifier
- PubMed Identifier: 8094623
- Open access
- false
- ISSN
- 0959-8049
- Ausgabe der Veröffentlichung
- 4
- Zeitschrift
- European journal of cancer (Oxford, England : 1990)
- Schlüsselwörter
- Endometrium
- Humans
- Adenocarcinoma
- Endometrial Neoplasms
- Membrane Glycoproteins
- Neoplasm Proteins
- Antineoplastic Combined Chemotherapy Protocols
- Drug Resistance
- Aged
- Middle Aged
- Female
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Sprache
- eng
- Medium
- Paginierung
- 554 - 558
- Datum der Veröffentlichung
- 1993
- Status
- Published
- Datum der Datenerfassung
- 1993
- Titel
- High rate of expression of multidrug resistance-associated P-glycoprotein in human endometrial carcinoma and normal endometrial tissue.
- Sub types
- Research Support, Non-U.S. Gov't
- Journal Article
- Ausgabe der Zeitschrift
- 29A
Data source: Europe PubMed Central
- Abstract
- The overexpression of P-glycoprotein was studied in 10 normal endometrial controls (five from the proliferative and five from the secretory phase of the menstrual cycle) and in 23 endometrial carcinomas of different histological varieties, using the C219 and JSB-1 monoclonal antibodies. Three of the tumours had been previously treated with combination chemotherapy containing doxorubicin. All endometrial carcinomas, whether treated or untreated, as well as the normal endometrial controls from both the proliferative and the secretory phase of the menstrual cycle, overexpressed P-glycoprotein. This puts endometrial carcinoma into the same category as other tumours arising in organs which normally overexpress P-glycoprotein, all of which tend to be intrinsically resistant to chemotherapy.
- Autoren
- J Schneider
- T Efferth
- MM Centeno
- J Mattern
- FJ Rodríguez-Escudero
- M Volm
- Autoren-URL
- https://www.ncbi.nlm.nih.gov/pubmed/8094623
- DOI
- 10.1016/s0959-8049(05)80150-9
- ISSN
- 0959-8049
- Ausgabe der Veröffentlichung
- 4
- Zeitschrift
- Eur J Cancer
- Schlüsselwörter
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Adenocarcinoma
- Aged
- Antineoplastic Combined Chemotherapy Protocols
- Drug Resistance
- Endometrial Neoplasms
- Endometrium
- Female
- Humans
- Membrane Glycoproteins
- Middle Aged
- Neoplasm Proteins
- Sprache
- eng
- Country
- England
- Paginierung
- 554 - 558
- PII
- S0959-8049(05)80150-9
- Datum der Veröffentlichung
- 1993
- Status
- Published
- Datum, an dem der Datensatz öffentlich gemacht wurde
- 1993
- Titel
- High rate of expression of multidrug resistance-associated P-glycoprotein in human endometrial carcinoma and normal endometrial tissue.
- Sub types
- Journal Article
- Research Support, Non-U.S. Gov't
- Ausgabe der Zeitschrift
- 29A
Data source: PubMed
- Beziehungen:
- Property of